+110.8%
MRNA vs RPRX
+57.8%
+52.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | RPRX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | 0.0% | -3.4% | -3.4% |
| 7D | -10.1% | -4.0% | -6.1% | -8.0% |
| 30D | +126.7% | +4.9% | +121.8% | +125.5% |
| 3M | +184.1% | +9.4% | +174.8% | +177.5% |
| 6M | +143.3% | +33.3% | +110.0% | +118.4% |
| YTD | +359.9% | +59.0% | +300.9% | +284.6% |
| 1Y | +454.2% | +69.2% | +385.0% | +351.1% |
| 3Y | +26.0% | +124.1% | -98.1% | -9.1% |
| 5Y | -70.3% | +77.9% | -148.1% | -76.3% |
| All | +110.8% | +57.8% | +52.9% | +63.2% |
Cumulative growth
Daily Returns
Daily percentage return beside RPRX.
Daily Out/Under-Performance
Portfolio return minus RPRX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling